Affy Rolls Out Axiom Genotyping Platform, Inks 100K-Sample GWAS Deal with Kaiser, UCSF
October 20, 2009
Affy Rolls Out Axiom Genotyping Platform, Inks 100K-Sample GWAS Deal with Kaiser, UCSF
Axiom is Affy's first major new genotyping offering since the firm launched its 1.8-million-marker SNP Array 6.0 two years ago. Affy believes that Axiom's customizable format will give it an advantage in the highly competitive genome-wide association studies market.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Affymetrix to Debut New Population-Optimized Arrays for Association Studies
April 26, 2011 / BioArray News - Affy Marks End of 'Days of Fixed Content Arrays,' Reaffirms Sequencing Not a 'Strategic Fit'
January 19, 2010 / BioArray News - New Illumina Suit Alleges Affy's GeneTitan, GeneAtlas, ArrayStation Infringe IP
November 10, 2009 / BioArray News - Affy Posts 6 Percent Decrease in Q2 Sales as it Prepares to Launch Next-Gen Genotyping Offering
July 28, 2009 / BioArray News - Fall 2010 Trial Date Set for Illumina v. Affymetrix Array IP Infringement Suit
July 21, 2009 / BioArray News